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The unique capabilities of our brain as an information processor are critically
dependent on the correct function of some 10 billions of neurons, each of
which is connected to about 10 000 other neurons by way of synapses. Unlike
in electronic computers these connections are not rigid but adapt their coupling
strengths in response to the information flow in the system e a phenomenon
called synaptic plasticity. A dissection of the process of synaptic transmission
as well as of the mechanisms underlying plasticity is essential for understand-
ing some of the major neurological diseases. It has been known since the early
fifties, that synaptic transmission is initiated by the release of a signalling sub-
stance, the neurotransmitter, from the presynaptic neuron. This, in turn, is trig-
gered by an influx of Calcium ions (Ca++) into the nerve terminal. The
neurotransmitter, once liberated, induces an increase in the conductance of
the postsynaptic membrane. When synaptic strength changes during ‘plastic-
ity‘ this can be a consequence of changes in any of the steps of this compli-
cated process. Unfortunately, most nerve terminals are very small and not
readily accessible to detailed investigation, such that usually it is very difficult
to assign a given change to one of these molecular mechansims. Quite recently,
however, it was discovered that a specialized synapse in the auditory pathway,
the ‘Calyx of Held‘, has presynaptic terminals, which are large enough that
quantitative biophysical techniques can be applied. Particularly, the postsynap-
tic current can be measured precisely, while the presynaptic calcium concen-
tration ([Ca++]) can be increased or decreased e either by opening and closing
of Ca++ channels or by releasing Ca++ from a chemically caged form by pho-
tolysis. Furthermore, [Ca++] can be measured by introducing fluorescent Ca++
indicators into the terminal. Using these experimental possibilities, we have
studied the role of Ca++ and other second messengers in short-term changes
of synaptic strength. We found that there are two steps, which are strongly
modulated: i) action potential waveform and Ca++ influx is modulated in mul-
tiple ways by second messengers ii) during ongoing activity new synaptic ves-
icles have to be recruited, to replace those that have undergone exocytosis.
This step of recruitment is also modulated strongly by [Ca++], cAMP and other
second messengers. The release process itself e although steeply dependent on
[Ca++] e is relatively immune to other forms of modulation.
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Immediate early genes are genes that share the characteristic of having their
expression rapidly and transiently induced upon stimulation without depen-
dence on de novo protein synthesis. Our studies over recent years have dem-
onstrated that restenosis, angiogenesis and inflammation can be suppressed
using novel ‘‘anti-gene therapeutic’’ strategies targeting certain immediate-
early genes. We targeted the basic-region leucine zipper protein, c-Jun with
a catalytic DNA molecule, Dz13, a 34-bp oligonucleotide capable of cleaving
both murine and human c-Jun transcripts at position G967 or G1311 respec-
tively. Since both angiogenesis and inflammation depend on vascular perme-
ability, we investigated whether the DNAzyme, Dz13, could suppress retinal
neovascularisation in a murine model of proliferative retinopathy (ROP). We
demonstrated that knockdown of c-Jun by Dz13, inhibited retinal neovascular-
isation. The control DNAzyme, Dz13scr, a size-matched molecule retaining
the catalytic core, but with scrambled hybridizing arms was unable to influ-
ence neovascularisation. This led us to investigate whether Dz13 could influ-
ence a number of inflammatory processes. Dz13 suppressed vascular
permeability and transendothelial emigration of leukocytes in murine modelsof vascular permeability, acute inflammation and collagen antibody induced ar-
thritis (CAIA), whereas its scrambled counterpart, Dz13scr had no influence
over these processes. Treatment with Dz13 reduced vascular permeability
due to cutaneous anaphylactic challenge or VEGF administration in mice.
Dz13 also abrogated monocyte endothelial cell adhesion in vitro and abolished
leukocyte rolling, adhesion and extravasation in a rat model of inflammation.
Dz13 attenuated neutrophil infiltration in the lungs of mice challenged with en-
dotoxin, a model of acute inflammation. Dz13 also reduced joint swelling, in-
flammatory cell infiltration and bone erosion in a mouse model of rheumatoid
arthritis (CAIA). FITC-conjugated DNAzyme localised within the tissue and
was still catalytically-active 1 hr following intradermal injection. We demon-
strated a reduction in c-Jun immunoreactivity in Dz13-treated joint (CAIA),
lung (sepsis) and retina (ROP). Further, we showed that Dz13 blocks cyto-
kine-inducible endothelial c-Jun, E-selectin, ICAM-1, VCAM-1 and VE-cad-
herin expression but has no effect on JAM-1, PECAM-1, p-JNK-1 or c-Fos.
Previous studies by our group demonstrated that Dz13-mediated inhibition
of c-Jun leads to suppression of SMC proliferation and wound repair in vitro,
the reduction of neointima formation following a rat carotid artery injury
model, and markedly reduced intimal hyperplasia and increased lumen size
in balloon-injured segments in rabbits. Our recent findings thus implicate c-
Jun as a useful target for anti-inflammatory, anti-angiogenic and anti-restenotic
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SIRPa1 is a member of the signal regulatory protein (SIRP) family that un-
dergoes tyrosine phosphorylation and binds SHP-2 tyrosine phosphatase in re-
sponse to various mitogens. The expression levels of SIRPa1 were decreased
in human HCC tissues, as compared with the matched normal tissues. Exog-
enous expression of wild-type SIRPa1, but not of a mutant SIRPa1 lacking
the tyrosine phosphorylation sites, in SIRPa1 negative Huh7 human HCC cells
resulted in suppression of tumor cell growth both in vitro and in vivo. Treat-
ment of Huh7 transfectants with EGF or HGF induced tyrosine phosphoryla-
tion of SIRPa1 and its association with SHP-2, which were accompanied by
reduced ERK1 activation. Expression of SIRPa1 significantly suppressed ac-
tivation of NF-kB and also sensitized Huh7 cells to TNFa or cisplatin-induced
cell death. In addition, SIRPa1-transfected Huh7 cells displayed reduced cell
migration and cell spreading in a fashion that was dependent on SIRPa1/SHP-
2 complex formation. In conclusion, these results suggest a negative regulatory
effect of SIRPa1 on hepatocarcinogenesis through, at least in part, inhibition
of ERK and NF-kB pathway. The heightened sensitivity of cells restoring
SIRPa1 function could be exploited in the development of therapeutic regi-
mens which may potentiate the antineoplastic effect of conventional cytokines
or chemotherapeutic agents.TALKS ON SPECIAL TOPICSEPIGENETIC REGULATION OF GENE EXPRESSION BY
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H1 linker histones play a key role in the folding of chromatin into higher order
structures. Mice contain at least eight H1 subtypes that differ in expression
during development. Our previous studies showed that mice develop normally
when any one of six different H1 genes is inactivated homozygously, whereas
mice lacking three H1 subtypes, H1c, H1d and H1e, generated by three rounds
of gene inactivation in ES cells, die by mid-gestation with a broad range of
defects. To further understand the role of H1 in chromatin structure and
